FAST NEWS: Ascletis Pharma Soars after Expanding Production of Covid-19 Tablets
The latest: Ascletis Pharma Inc. (1672.HK) announced the expansion of its annual production capacity of ritonavir oral tablets, a component of oral direct-acting Covid-19 drug paxlovid, to 100 million tablets,…
RELATED ARTICLES
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK -
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
CSPC Pharma weighs up diet drug for bigger bottom line
1093.HK
-
CSPC Pharma taps R&D superstar in quest for new breakout drugs
1093.HK
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
